CMRA Insider Trading Activity and SEC Form 4 Filings
CMRA insider trading summary
No open-market insider purchases or sales of Comera Life Sciences Holdings, Inc. (CMRA) have been reported on SEC Form 4 in the past 12 months.
Latest CMRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 27, 2023 | Michael Gerard Campbell | EVP & CFO | Buy | $708 (10,000 @ $0.07) |
| Sep 11, 2023 | Soane Family Trust | 10% Owner | Buy | $30K (58,680 @ $0.51) |
| Sep 11, 2023 | Charles Cherington | 10% Owner | Buy | $1.0M (2,053,789 @ $0.51) |
| Sep 11, 2023 | David Soane | 10% Owner | Buy | $30K (58,680 @ $0.51) |
| Aug 14, 2023 | Robert Patrick Mahoney | Chief Scientific Officer | Buy | $13K (20,000 @ $0.63) |
| Jul 31, 2023 | Charles Cherington | 10% Owner | Buy | $450K (880,195 @ $0.51) |
| Jul 31, 2023 | David Soane | 10% Owner | Buy | $70K (136,919 @ $0.51) |
| Jul 31, 2023 | Soane Family Trust | 10% Owner | Buy | $70K (136,919 @ $0.51) |
| Jan 4, 2023 | Charles Cherington | 10% Owner | Buy | $914K (743,243 @ $1.23) |
| Jan 4, 2023 | David Soane | 10% Owner | Buy | $83K (67,567 @ $1.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.